Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| DMF 15551 | |||
| IND 68617 |
Not provided
Not provided
Not provided
Subject recuitment halted and won't resume; subjects are no longer being treated.
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Nitric BioTherapeutics, Inc | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To determine the effects of topically applied ViaNOx-H for 8 hours daily for 2 weeks on the reduction of the bio-burden in biofilms on chronic non-healing wounds as recorded by measurements of wound size and wound culture.
The primary goal of this study is to determine the effects of topically applied gaseous nitric oxide on the bio-burden of chronic non-healing wounds of the lower extremities. Reports will include:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Topically applied Nitric Oxide | Experimental | Topically applied Nitric Oxide for 8 hours daily for 2 weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nitric Oxide | Drug | Topically applied gaseous nitric oxide at 8 to 10 parts per million, for 8 hours each night for 14 nights. |
|
| Measure | Description | Time Frame |
|---|---|---|
| The Primary Endpoint is the Eradication of the Bio-burden as Measured by a Reduction in Culture Growth to ≤ +2. | at 28 days post enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| The Secondary Endpoint Measure is a Reduction on Wound Size. | reduction in bioburden as assessed by number of cfu's per cm2 on culture | 28 days post enrollment |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Takkin Lo, MD, MPH | Loma Linda University Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Loma Linda University Medical Center | Loma Linda | California | 92354 | United States |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Topically Applied Nitric Oxide | Topically applied gaseous nitric oxide at 8 to 10 parts per million, for 8 hours each night for 14 nights. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Group 1 | Treatment |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | The Primary Endpoint is the Eradication of the Bio-burden as Measured by a Reduction in Culture Growth to ≤ +2. | Data not available for this study due to dissolution of company contracted to perform study analysis | Posted | at 28 days post enrollment |
|
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Group 1 | Treatment |
Not provided
Not provided
No data available for this study due to dissolution of company contracted to perform study analysis.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Deborah Dodge | Loma Linda University Medical Center | (909) 558-4000 | 48500 | ddodge@llu.edu |
Not provided
| ID | Term |
|---|---|
| D009569 | Nitric Oxide |
| ID | Term |
|---|---|
| D026361 | Reactive Nitrogen Species |
| D005609 | Free Radicals |
| D007287 | Inorganic Chemicals |
| D009589 | Nitrogen Oxides |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Participants |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Evidence of a colonized wound on the lower extremity. | Number | participants |
|
| Secondary | The Secondary Endpoint Measure is a Reduction on Wound Size. | reduction in bioburden as assessed by number of cfu's per cm2 on culture | Data not available for this study due to dissolution of company contracted to perform analysis. | Posted | 28 days post enrollment |
|
|
| 0 |
| 7 |
| 0 |
| 7 |
Not provided
Not provided
| D017672 |
| Nitrogen Compounds |
| D010087 | Oxides |
| D017601 | Oxygen Compounds |
| D009930 | Organic Chemicals |